Return On Assets of Carisma Therapeutics Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Carisma Therapeutics Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Carisma Therapeutics Inc. Return On Assets for the quarter ending 30 Sep 2025 was 55%.
  • Carisma Therapeutics Inc. annual Return On Assets for 2024 was -118%, a 64% decline from 2023.
  • Carisma Therapeutics Inc. annual Return On Assets for 2023 was -72%, a 97% decline from 2022.
  • Carisma Therapeutics Inc. annual Return On Assets for 2022 was -36%, a 24339% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Carisma Therapeutics Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 55% +152% 01 Jul 2025 30 Sep 2025
Q2 2025 -211% -123% -140% 01 Apr 2025 30 Jun 2025
Q1 2025 -137% -57% -70% 01 Jan 2025 31 Mar 2025
Q4 2024 -118% -46% -64% 01 Oct 2024 31 Dec 2024
Q3 2024 -96% -26% -36% 01 Jul 2024 30 Sep 2024
Q2 2024 -88% -31% -55% 01 Apr 2024 30 Jun 2024
Q1 2024 -81% -31% -63% 01 Jan 2024 31 Mar 2024
Q4 2023 -72% -35% -97% 01 Oct 2023 31 Dec 2023
Q3 2023 -71% -54% -319% 01 Jul 2023 30 Sep 2023
Q2 2023 -57% -82% -329% 01 Apr 2023 30 Jun 2023
Q1 2023 -49% -68% -365% 01 Jan 2023 31 Mar 2023
Q4 2022 -36% -36% -24339% 01 Oct 2022 31 Dec 2022
Q3 2022 -17% -5% -36% 01 Jul 2022 30 Sep 2022
Q2 2022 25% +97% 01 Apr 2022 30 Jun 2022
Q1 2022 19% +111% 01 Jan 2022 31 Mar 2022
Q4 2021 0% +20% +99% 01 Oct 2021 31 Dec 2021
Q3 2021 -12% +26% +68% 01 Jul 2021 30 Sep 2021
Q2 2021 -72% -43% -151% 01 Apr 2021 30 Jun 2021
Q1 2021 -92% -41% -80% 01 Jan 2021 31 Mar 2021
Q4 2020 -20% +72% +78% 01 Oct 2020 31 Dec 2020
Q3 2020 -38% +31% +45% 01 Jul 2020 30 Sep 2020
Q2 2020 -29% +42% +59% 01 Apr 2020 30 Jun 2020
Q1 2020 -51% -20% -62% 01 Jan 2020 31 Mar 2020
Q4 2019 -92% -61% -197% 01 Oct 2019 31 Dec 2019
Q3 2019 -70% -36% -107% 01 Jul 2019 30 Sep 2019
Q2 2019 -70% -38% -116% 01 Apr 2019 30 Jun 2019
Q1 2019 -31% +2% +5.7% 01 Jan 2019 31 Mar 2019
Q4 2018 -31% +3% +8.9% 01 Oct 2018 31 Dec 2018
Q3 2018 -34% -6% -20% 01 Jul 2018 30 Sep 2018
Q2 2018 -33% -35% -1291% 01 Apr 2018 30 Jun 2018
Q1 2018 -33% -38% -816% 01 Jan 2018 31 Mar 2018
Q4 2017 -34% -38% -1032% 01 Oct 2017 31 Dec 2017
Q3 2017 -28% -14% -100% 01 Jul 2017 30 Sep 2017
Q2 2017 3% +129% 01 Apr 2017 30 Jun 2017
Q1 2017 5% +94% 01 Jan 2017 31 Mar 2017
Q4 2016 4% +76% 01 Oct 2016 31 Dec 2016
Q3 2016 -14% +47% +77% 01 Jul 2016 30 Sep 2016
Q2 2016 -126% -60% -90% 01 Apr 2016 30 Jun 2016
Q1 2016 -90% -17% -24% 01 Jan 2016 31 Mar 2016
Q4 2015 -72% -1% -2.1% 01 Oct 2015 31 Dec 2015
Q3 2015 -61% +22% +26% 01 Jul 2015 30 Sep 2015
Q2 2015 -67% 01 Apr 2015 30 Jun 2015
Q1 2015 -72% 01 Jan 2015 31 Mar 2015
Q4 2014 -70% 01 Oct 2014 31 Dec 2014
Q3 2014 -83% 01 Jul 2014 30 Sep 2014

Carisma Therapeutics Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -118% -46% -64% 01 Jan 2024 31 Dec 2024
2023 -72% -35% -97% 01 Jan 2023 31 Dec 2023
2022 -36% -36% -24339% 01 Jan 2022 31 Dec 2022
2021 0% +20% +99% 01 Jan 2021 31 Dec 2021
2020 -20% +72% +78% 01 Jan 2020 31 Dec 2020
2019 -92% -61% -197% 01 Jan 2019 31 Dec 2019
2018 -31% +3% +8.9% 01 Jan 2018 31 Dec 2018
2017 -34% -38% -1032% 01 Jan 2017 31 Dec 2017
2016 4% +76% 01 Jan 2016 31 Dec 2016
2015 -72% -1% -2.1% 01 Jan 2015 31 Dec 2015
2014 -70% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.